Advertisement

India goes digital to track cough syrup ingredients after child deaths

The Central Drugs Standard Control Organisation (CDSCO) has directed regulators and manufacturers to register in the Online National Drug Licensing System (ONDLS) portal for real-time monitoring of solvent batches

Advertisement
Nilesh Suryavanshi, 32, the father of a 3 year old child who has been admitted at the Government Medical College, holds a bottle of Coldrif cough syrup, which has been linked to the deaths of 17 children, in Nagpur, India, on October 8, 2025. Reuters File
Nilesh Suryavanshi, 32, the father of a 3 year old child who has been admitted at the Government Medical College, holds a bottle of Coldrif cough syrup, which has been linked to the deaths of 17 children, in Nagpur, India, on October 8, 2025. Reuters File
FP News Desk|Oct 23, 2025, 11:20:02 IST

India has launched a digital tracking system to monitor the movement, production and ingredients used in cough syrups as the government cracks down on contamination of the medicines, following the deaths of children in Madhya Pradesh.

According to a report by News18, the Central Drugs Standard Control Organisation (CDSCO) has directed regulators and manufacturers to register in the Online National Drug Licensing System (ONDLS) portal for real-time monitoring of solvent batches.

Advertisement

The move comes after the World Health Organisation said India has more work to do in halting sales of toxic cough syrup, despite some progress. The children died after taking the Coldrif cough medicine made by Sresan Pharma, which tests showed contained the toxin diethylene glycol in quantities nearly 500 times the permissible limit.

healthMore from Health

What are the new measures?

A CDSCO document has identified 10 solvents classified as high-risk, including glycerin, propylene glycol, sorbitol, maltitol, and ethyl alcohol, ingredients commonly used in syrups and other liquid medications. The new digital system aims to formalise oversight and address gaps in the monitoring of these raw materials, the document said.

“It has been decided that a Digital Monitoring System on the ONDLS portal needs to be established for monitoring the supply chain as well as quality of the high-risk solvents including the propylene glycol. Accordingly, the ONDLS portal has been upgraded and made live by this directorate for addressing this issue," CDSCO said.

Advertisement

Under the new system, all pharmaceutical manufacturers are required to obtain manufacturing licences through the ONDLS portal and submit real-time information about every batch that is produced.

Each batch record must provide details, including the batch number, quantity, certificate of analysis (CoA), and information about the buyer or vendor receiving the solvent. State regulators have been instructed to ensure that no batch is released to the market until all required data has been digitally uploaded and verified on the portal.

Handpicked stories, in your inbox
Global stories. Indian perspective. Zero noise.
No Spam. Unsubscribe Any Time.
First Published:Oct 23, 2025, 11:20:02 IST
Advertisement
Advertisement
Trending Stories

Stroke is rising among young adults. Doctor explains why it's happening and what you must do

Stroke is increasingly affecting adults in their 30s, 40s and 50s. Experts say unhealthy lifestyles, undiagnosed high blood pressure and delayed treatment are driving the rise in younger stroke cases
3 min read
Advertisement
Advertisement
Up Next